148 related articles for article (PubMed ID: 15721275)
1. Lysophosphatidylcholine induces tPA gene expression through CRE-dependent mechanism.
Sheikh AM; Ochi H; Masuda J
Biochem Biophys Res Commun; 2005 Apr; 329(1):71-7. PubMed ID: 15721275
[TBL] [Abstract][Full Text] [Related]
2. NF1 regulatory element functions as a repressor of tissue plasminogen activator expression.
Pham NL; Franzen A; Levin EG
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):982-7. PubMed ID: 15044208
[TBL] [Abstract][Full Text] [Related]
3. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
[TBL] [Abstract][Full Text] [Related]
4. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
5. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.
Muldowney JA; Stringham JR; Levy SE; Gleaves LA; Eren M; Piana RN; Vaughan DE
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):400-6. PubMed ID: 17158352
[TBL] [Abstract][Full Text] [Related]
7. Regulation of plasminogen activator activity and expression by cyclic mechanical stress in rat mandibular condylar chondrocytes.
Chen W; Tang Y; Zheng M; Jiang J; Zhu G; Liang X; Li M
Mol Med Rep; 2013 Oct; 8(4):1155-62. PubMed ID: 23982192
[TBL] [Abstract][Full Text] [Related]
8. Effects of two complex hemodynamic stimulation profiles on hemostatic genes in a vessel-like environment.
Bergh N; Ulfhammer E; Karlsson L; Jern S
Endothelium; 2008; 15(5-6):231-8. PubMed ID: 19065314
[TBL] [Abstract][Full Text] [Related]
9. Tissue-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA and their protein expression levels in human decidua after early pregnancy termination by mifepristone plus misoprostol.
Huang L; Shi Y
Chin Med J (Engl); 2001 Jun; 114(6):628-31. PubMed ID: 11780441
[TBL] [Abstract][Full Text] [Related]
10. Sesamol regulates plasminogen activator gene expression in cultured endothelial cells: a potential effect on the fibrinolytic system.
Chen PR; Lee CC; Chang H; Tsai CE
J Nutr Biochem; 2005 Jan; 16(1):59-64. PubMed ID: 15629242
[TBL] [Abstract][Full Text] [Related]
11. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
[TBL] [Abstract][Full Text] [Related]
12. Induction of the urokinase plasminogen activator system by oncostatin M promotes endothelial migration.
Strand K; Murray J; Aziz S; Ishida A; Rahman S; Patel Y; Cardona C; Hammond WP; Savidge G; Wijelath ES
J Cell Biochem; 2000 Aug; 79(2):239-48. PubMed ID: 10967551
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
14. Hormonal regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 gene expression in cultured mouse Sertoli cells.
Liu YX; Du Q; Hu ZY; Tor N
Sci China B; 1993 Mar; 36(3):319-28. PubMed ID: 8397803
[TBL] [Abstract][Full Text] [Related]
15. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
Skeldal S; Larsen JV; Pedersen KE; Petersen HH; Egelund R; Christensen A; Jensen JK; Gliemann J; Andreasen PA
FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782
[TBL] [Abstract][Full Text] [Related]
16. Astrocyte regulation of endothelial tissue plasminogen activator in a blood-brain barrier model.
Tran ND; Schreiber SS; Fisher M
J Cereb Blood Flow Metab; 1998 Dec; 18(12):1316-24. PubMed ID: 9850144
[TBL] [Abstract][Full Text] [Related]
17. Activation of tissue plasminogen activator gene transcription by Neovastat, a multifunctional antiangiogenic agent.
Gingras D; Nyalendo C; Di Tomasso G; Annabi B; Béliveau R
Biochem Biophys Res Commun; 2004 Jul; 320(1):205-12. PubMed ID: 15207722
[TBL] [Abstract][Full Text] [Related]
18. Induction of plasminogen activator inhibitor-1 and -2 in dorsal root ganglion neurons after peripheral nerve injury.
Yamanaka H; Obata K; Fukuoka T; Dai Y; Kobayashi K; Tokunaga A; Noguchi K
Neuroscience; 2005; 132(1):183-91. PubMed ID: 15780477
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism.
Calin-Jageman IE; Wang J; Bannon MJ
J Neurochem; 2006 Apr; 97(1):255-64. PubMed ID: 16515544
[TBL] [Abstract][Full Text] [Related]
20. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]